RANKINGS

POPULAR STOCKS

IXICO plc

LSE:IXI.L

Location

United Kingdom

Market Cap

USD 13.91 M

Share Price

USD 0.15

Avg Daily Volume

57,055

Change (1 day)

-0.13%

Change (1 year)

68.54%

Change (YTD)

5.20%

IXICO plc Operating Income for the year ending September 30, 2024: USD -2.88 M

IXICO plc Operating Income is USD -2.88 M for the year ending September 30, 2024, a 64.29% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • IXICO plc Operating Income for the year ending September 30, 2023 was USD -1.75 M, a -1,516.03% change year over year.
  • IXICO plc Operating Income for the year ending September 30, 2022 was USD 123.83 K, a -86.83% change year over year.
  • IXICO plc Operating Income for the year ending September 30, 2021 was USD 940.25 K, a 208.57% change year over year.
  • IXICO plc Operating Income for the year ending September 30, 2020 was USD 304.71 K, a -31.87% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
LSE: IXI.L

IXICO plc

CEO Mr. Bram Goorden M.Sc.
IPO Date April 25, 1996
Location United Kingdom
Headquarters Griffin Court
Employees 81
Sector 🏥 Health Care
Industries
Clinical Trials
🤖 Artificial Intelligence (AI)
📊 Big Data
💻 Telehealth
Description

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

Similar companies

NTRA

Natera, Inc.

USD 171.86

0.52%

VCYT

Veracyte, Inc.

USD 26.39

-1.60%

BSX

Boston Scientific Corporation

USD 101.30

-0.07%

REL.L

RELX Plc

USD 52.39

-0.44%

SHL.DE

Siemens Healthineers AG

USD 53.26

0.96%

COR

Cencora, Inc.

USD 293.66

-1.04%

EW

Edwards Lifesciences Corporation

USD 73.83

-0.20%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

DXCM

DexCom, Inc.

USD 80.00

-1.25%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

IQV

IQVIA Holdings Inc.

USD 154.73

0.08%

LH

Laboratory Corporation of America Holdings

USD 261.88

0.19%

BAX

Baxter International Inc.

USD 29.99

0.64%

ILMN

Illumina, Inc.

USD 90.49

0.26%

HOLX

Hologic, Inc.

USD 64.48

0.80%

SGI

Somnigroup International Inc

USD 65.30

0.49%

FPH.NZ

Fisher & Paykel Healthcare Corporation Limited

USD 21.87

-1.54%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

ICLR

ICON Public Limited Company

USD 146.48

2.02%

ZYDUSLIFE.NS

Zydus Lifesciences Limited

USD 11.05

0.84%

ASND

Ascendis Pharma A/S

USD 176.90

3.63%

PEN

Penumbra, Inc.

USD 256.87

-0.05%

EXAS

Exact Sciences Corporation

USD 53.02

1.30%

CTEC.L

ConvaTec Group Plc

USD 3.81

1.16%

ABBOTINDIA.NS

Abbott India Limited

USD 364.99

2.00%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.10

-0.68%

002252.SZ

Shanghai RAAS Blood Products Co., Ltd.

USD 0.95

-0.05%

GH

Guardant Health, Inc.

USD 49.14

-2.83%

AFX.DE

Carl Zeiss Meditec AG

USD 63.19

-5.29%

DIA.MI

DiaSorin S.p.A.

USD 108.71

1.66%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.61

-0.28%

LNTH

Lantheus Holdings, Inc.

USD 79.19

0.25%

688617.SS

APT Medical Inc.

USD 38.32

1.54%

TFX

Teleflex Incorporated

USD 118.31

0.50%

OPCH

Option Care Health, Inc.

USD 31.53

-0.10%

600079.SS

Humanwell Healthcare (Group) Co.,Ltd.

USD 2.90

0.88%

IRTC

iRhythm Technologies, Inc.

USD 145.74

0.14%

ADMA

ADMA Biologics, Inc.

USD 17.74

-2.15%

RDNT

RadNet, Inc.

USD 55.23

-3.31%

TMDX

TransMedics Group, Inc.

USD 123.56

-0.36%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.51

0.83%

002065.SZ

DHC Software Co.,Ltd.

USD 1.23

-0.62%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.63

-0.48%

INSP

Inspire Medical Systems, Inc.

USD 130.91

0.93%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.82

0.10%

GLAND.NS

Gland Pharma Limited

USD 19.89

1.04%

PRCT

PROCEPT BioRobotics Corporation

USD 60.22

0.94%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.94

0.32%

MOVE.SW

Medacta Group SA

USD 159.10

-0.62%

ICUI

ICU Medical, Inc.

USD 127.74

-0.65%

StockViz Staff

June 21, 2025

Any question? Send us an email